Emma Wang

CDO&CTO at YolTech Therapeutics

Speaker

Emma brings to YolTech more than 10 years of experience in the pharmaceutical and biotechnology industry. Prior to YolTech, Emma spent more than five years working in mRNA/LNP drug product development, formulation development, process and analytical development, technical transfer, CMC strategy at Beam, Tessera and Providence Therapeutics.

As chief development and technical officer at YolTech, Emma oversees platform and pipeline research activities and manages a multidisciplinary team in drug product development, CMC, manufacturing, regulatory affairs, quality and early clinical development. She holds a B.Eng and M.Eng in Chemical Engineering from McGill University in Canada and Ph.D in Chemistry from Max Planck Institute for Polymer Research in Germany.